Stem Cell Therapy Market will expand at 10%+ CAGR up to 2025

European stem cell therapy market is anticipated to witness around 10% growth during analysis time frame. Substantial growth is attributed to increasing prevalence of chronic diseases in the region. Moreover, the regulatory scenario for stem cell therapies is also improving gradually. Initially stringent regulations lowered the demand for stem cell therapies. However, as people started becoming aware regarding advantages associated with stem cell therapy, its adoption escalated. Above-mentioned factors fosters the regional growth.

Clinics segment of stem cell therapy market accounted for around 35% revenue share in 2018. Clinics are equipped with advanced medical equipment and skilled professionals that enables it to provide superior quality stem cell therapies. Clinics can deliver specialized stem cell treatment in areas such as cardiovascular, oncology or orthopedics that should prove beneficial for the segment growth. However, as the treatments offered at clinics are expensive, that may have a short term impact on the segment growth.

Orthopedic segment is anticipated to witness more than 9% growth over the forecast time frame. Substantial growth is attributed to rising accidents and trauma cases across the globe. Stem cell therapy is successfully applicable in treating bone-joint injuries that include spinal and fractured bone defects, ligament tendon, femoral head and osteogenesis imperfecta. Mesenchymal stem cell therapy is preferred in curing orthopedic diseases such as arthritis and osteoporosis due to its ability to differentiate into bones and cartilage. Above mentioned factors will surge segment growth.

Allogenic stem cell therapy market segment was valued USD 3 billion in 2018 and is anticipated to expand substantially in near future. Allogenic transplant completely replaces host cells with donor cells. It also has the potential to eliminate viral reservoirs and genetic alterations. Therefore, allogenic stem cell therapies have been extensively utilized in providing treatment to patients suffering from leukemia and several other life threatening diseases. Thus, benefits offered by allogenic stem cell therapy will surge its demand, thereby propelling segment growth.

To access a sample copy of "Stem Cell Therapy Market" report in detail along with the table of contents @ https://www.gminsights.com/request-sample/detail/3331

Prominent industry players operational in the stem cell therapy market include Astellas Pharma, Cellectis, Celyad, ReNeuron Group, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, Novadip Biosciences, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, and Takeda Pharmaceuticals.

Global Stem Cell Therapy Market revenue is set to surpass USD 15 billion by 2025; as per a new research report published by Global Market Insights, Inc. Rising geriatric population will positively influence the industry growth in coming years. Elderly people are susceptible to degenerative diseases such as Parkinson?s and Alzheimer?s disorders. Stem cell therapies offer several benefits over the conventional therapeutic methods that raises its preference for curing degenerative diseases. Recently developed stem cell therapies generate healthy cells by replacing the defective cells through minimally invasive techniques. Therefore, geriatric population rely on stem cell therapies that proves beneficial for the industry growth.